{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:57:34Z","timestamp":1792396654961,"version":"4.4.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029199","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T21:38:46Z","timestamp":1324589926000},"page":"e29199","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":83,"title":["Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments"],"prefix":"10.1371","volume":"6","author":[{"given":"David C.","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Messer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/35039051","article-title":"Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease.","volume":"1","author":"JF Gusella","year":"2000","journal-title":"Nat Rev Neurosci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ana.410420411","article-title":"Huntingtin localization in brains of normal and Huntington's disease patients.","volume":"42","author":"E Sapp","year":"1997","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","article-title":"Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.","volume":"4","author":"MW Becher","year":"1998","journal-title":"Neurobiol Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.","volume":"90","author":"SW Davies","year":"1997","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.","volume":"102","author":"EJ Slow","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1074\/jbc.M804813200","article-title":"Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells.","volume":"284","author":"T Ratovitski","year":"2009","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","article-title":"Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo.","volume":"30","author":"RK Graham","year":"2010","journal-title":"J Neurosci"},{"key":"ref9","article-title":"Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.","author":"DC Butler","year":"2011","journal-title":"Progress in Neurobiology:"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/14712590903176387","article-title":"Developing intrabodies for the therapeutic suppression of neurodegenerative pathology.","volume":"9","author":"A Messer","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00063030-200620060-00002","article-title":"The therapeutic potential of intrabodies in neurologic disorders: focus on huntington and Parkinson diseases.","volume":"20","author":"A Messer","year":"2006","journal-title":"Biodrugs"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molmed.2008.07.004","article-title":"The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases.","volume":"14","author":"A Cardinale","year":"2008","journal-title":"Trends Mol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/bies.201000009","article-title":"Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.","volume":"32","author":"D Perez-Martinez","year":"2010","journal-title":"Bioessays"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.","volume":"16","author":"RS Atwal","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export.","volume":"37","author":"J Cornett","year":"2005","journal-title":"Nat Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2007.11.018","article-title":"14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.","volume":"431","author":"K Omi","year":"2008","journal-title":"Neurosci Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","article-title":"The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.","volume":"16","author":"E Rockabrand","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e5727","DOI":"10.1371\/journal.pone.0005727","article-title":"Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.","volume":"4","author":"E Kvam","year":"2009","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1073\/pnas.071058398","article-title":"Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease.","volume":"98","author":"J-M Lecerf","year":"2001","journal-title":"PNAS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nbd.2004.11.003","article-title":"A human single-chain Fv intrabody preferentially targets amino-terminal huntingtin fragments in striatal models of Huntington's disease.","volume":"19","author":"TW Miller","year":"2005","journal-title":"Neurobiol Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molbrainres.2003.11.011","article-title":"A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's disease.","volume":"121","author":"RC Murphy","year":"2004","journal-title":"Brain Res Mol Brain Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1096\/fj.07-099689","article-title":"Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease.","volume":"22","author":"JA McLear","year":"2008","journal-title":"FASEB J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/NEN.0b013e3181f530ec","article-title":"Messer A Early or late-stage anti-N-terminal Huntingtin intrabody gene therapy reduces pathological features in B6.HDR6\/1 mice.","volume":"69","author":"A Snyder-Keller","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1126\/science.2928784","article-title":"Prevention of rapid intracellular degradation of ODC by a carboxyl-terminal truncation.","volume":"243","author":"L Ghoda","year":"1989","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"34970","DOI":"10.1074\/jbc.273.52.34970","article-title":"Generation of destabilized green fluorescent protein as a transcription reporter.","volume":"273","author":"X Li","year":"1998","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2144\/00293rr02","article-title":"Development of a destabilized firefly luciferase enzyme for measurement of gene expression.","volume":"29","author":"GM Leclerc","year":"2000","journal-title":"Biotechniques"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1111\/j.1742-4658.2005.04709.x","article-title":"Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells.","volume":"272","author":"AP Sibler","year":"2005","journal-title":"FEBS J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/exnr.2000.7551","article-title":"ST14A cells have properties of a medium-size spiny neuron.","volume":"167","author":"ME Ehrlich","year":"2001","journal-title":"Exp Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"17616","DOI":"10.1073\/pnas.0408134101","article-title":"Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.","volume":"101","author":"DW Colby","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jmb.2004.07.054","article-title":"Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.","volume":"342","author":"DW Colby","year":"2004","journal-title":"J Mol Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1471-4159.2007.05032.x","article-title":"Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.","volume":"104","author":"A Weiss","year":"2008","journal-title":"J Neurochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/protein\/gzq022","article-title":"Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.","volume":"23","author":"E Kvam","year":"2010","journal-title":"Protein Eng Des Sel"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","article-title":"PEST sequences and regulation by proteolysis.","volume":"21","author":"M Rechsteiner","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1073\/pnas.96.18.10403","article-title":"Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.","volume":"96","author":"L Meng","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/hmg\/11.22.2689","article-title":"Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.","volume":"11","author":"LG Verhoef","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/protein\/gzl036","article-title":"Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies.","volume":"19","author":"H Barkhordarian","year":"2006","journal-title":"Protein Eng Des Sel"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.","volume":"10","author":"NR Jana","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1523\/JNEUROSCI.2747-08.2008","article-title":"Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity.","volume":"28","author":"AL Southwell","year":"2008","journal-title":"J Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.","volume":"29","author":"AL Southwell","year":"2009","journal-title":"J Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.022631799","article-title":"Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity.","volume":"99","author":"A Khoshnan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nchembio.604","article-title":"Huntington's disease: flipping a switch on huntingtin.","volume":"7","author":"ER Greiner","journal-title":"Nat Chem Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.0505321102","article-title":"Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies.","volume":"102","author":"WJ Wolfgang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington's disease.","volume":"90","author":"C Zuccato","year":"2010","journal-title":"Physiol Rev"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/hmg\/ddi423","article-title":"Proteasome impairment does not contribute to pathogenesis in R6\/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.","volume":"15","author":"JS Bett","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington's disease.","volume":"448","author":"EJ Bennett","year":"2007","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1128\/MCB.19.10.7216","article-title":"ATP-Dependent inactivation and sequestration of ornithine decarboxylase by the 26S proteasome are prerequisites for degradation.","volume":"19","author":"Y Murakami","year":"1999","journal-title":"Mol Cell Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/j.1742-4658.2008.06562.x","article-title":"Huntington's disease: degradation of mutant huntingtin by autophagy.","volume":"275","author":"S Sarkar","year":"2008","journal-title":"FEBS J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","article-title":"The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin.","volume":"10","author":"W Auerbach","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/hmg\/ddm217","article-title":"Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity.","volume":"16","author":"RS Atwal","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/hmg\/ddi340","article-title":"Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.","volume":"14","author":"CL Benn","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.","volume":"285","author":"C Landles","year":"2010","journal-title":"J Biol Chem"},{"key":"ref52","article-title":"A Disulfide-Free Single-Domain V(L) Intrabody with Blocking Activity towards Huntingtin Reveals a Novel Mode of Epitope Recognition.","author":"A Schiefner","journal-title":"J Mol Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ymthe.2005.04.003","article-title":"Intrabody applications in neurological disorders: progress and future prospects.","volume":"12","author":"TW Miller","year":"2005","journal-title":"Mol Ther"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/jmbi.1998.1840","article-title":"Expression of an antibody fragment at high levels in the bacterial cytoplasm.","volume":"280","author":"P Martineau","year":"1998","journal-title":"J Mol Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1073\/pnas.95.11.6157","article-title":"Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens.","volume":"95","author":"MD Sheets","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0076-6879(00)26070-9","article-title":"Methods for generating multivalent and bispecific antibody fragments.","volume":"326","author":"I Tomlinson","year":"2000","journal-title":"Methods Enzymol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1093\/nar\/28.15.e72","article-title":"By-passing selection: direct screening for antibody-antigen interactions using protein arrays.","volume":"28","author":"LJ Holt","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jmb.2007.09.053","article-title":"A protein silencing switch by ligand-induced proteasome-targeting intrabodies.","volume":"374","author":"T Melchionna","year":"2007","journal-title":"J Mol Biol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.","volume":"97","author":"JS Steffan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nmeth901","article-title":"An improved mRFP1 adds red to bimolecular fluorescence complementation.","volume":"3","author":"G Jach","year":"2006","journal-title":"Nat Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:12:28Z","timestamp":1713247948000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029199"}},"subtitle":[],"editor":[{"given":"Philipp J.","family":"Kahle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029199","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,22]]}}}